AbCellera Biologics Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
AbCellera Biologics Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does AbCellera Biologics Inc. do? Business model and key facts
Get the full picture of AbCellera Biologics Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 562
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Stocks related to AbCellera Biologics Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting AbCellera Biologics Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
AbCellera Biologics Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
